During fatty liver graft injury, arachidonic acid activates the NLRP3 inflammasome in MDSCs through FATP2, leading to increased IL-17 secretion by CD4+ T cells and promoting tumor recurrence post-transplantation 108. This evidence concerns the gene CD4 and neoplasm.